Maternal and Infant Syphilis Prevention Act
This bill requires the federal government to issue guidance to state Medicaid programs within 12 months to improve syphilis screening for pregnant women and newborns. It specifically encourages states to expand third-trimester and delivery screenings, integrate telehealth services, provide multilingual education for providers and patients, and enhance treatment protocols. The guidance aims to prevent congenital syphilis - where syphilis is passed from mother to baby during pregnancy - which caused over 3,700 newborn cases in 2022. States must report on implementing these practices to Congress within two years. The bill directly affects pregnant women, newborns, and Medicaid providers by standardizing and improving access to critical syphilis prevention services.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jun 2024
Committee Review
Floor Vote
President
Introduced Jun 26, 2024
Last action Jun 26, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jun 26, 2024
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jun 26, 2024
Introduced
Introduced in House
lower
1 primary · 10 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Yadira Caraveo
DDemocratic
Co
André Carson
DDemocratic
Co
Bonnie Watson Coleman
DDemocratic
Co
Colin Z. Allred
DDemocratic
Co
Eleanor Holmes Norton
DDemocratic
Co
Jerrold Nadler
DDemocratic
Co
Juan Ciscomani
RRepublican
Co
Raúl M. Grijalva
DDemocratic
Co
Robert Garcia
DDemocratic
Co
Steve Cohen
DDemocratic
Co
Yvette D. Clarke
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 8839
Scope: US
Hi! I can help you understand HR 8839. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline